These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 36553684)
1. Impact of X-Linked Hypophosphatemia on Muscle Symptoms. Romagnoli C; Iantomasi T; Brandi ML Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553684 [TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of burosumab in improving phosphate metabolism, bone health, and quality of life in adolescents with X-linked hypophosphatemic rickets. Baroncelli GI; Grandone A; Aversa A; Sessa MR; Pelosini C; Michelucci A; Toschi B; Manca M; Isola A; Comberiati P Eur J Med Genet; 2024 Aug; 70():104958. PubMed ID: 38950880 [TBL] [Abstract][Full Text] [Related]
3. FGF23 and its role in X-linked hypophosphatemia-related morbidity. Beck-Nielsen SS; Mughal Z; Haffner D; Nilsson O; Levtchenko E; Ariceta G; de Lucas Collantes C; Schnabel D; Jandhyala R; Mäkitie O Orphanet J Rare Dis; 2019 Feb; 14(1):58. PubMed ID: 30808384 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of X-linked hypophosphatemia in children and adolescent in the Gulf Cooperation Council countries. Al Juraibah F; Al Amiri E; Al Dubayee M; Al Jubeh J; Al Kandari H; Al Sagheir A; Al Shaikh A; Beshyah SA; Deeb A; Habeb A; Mustafa M; Zidan H; Mughal MZ Arch Osteoporos; 2021 Mar; 16(1):52. PubMed ID: 33660084 [TBL] [Abstract][Full Text] [Related]
5. Spectrum of PHEX Mutations and FGF23 Profiles in a Taiwanese Cohort With X-Linked Hypophosphatemia Including 102 Patients. Su PH; Yu JS; Wu YZ; Tsai YS; Lo FS; Lin JL; Chao MC; Hsu CC; Ke YY; Chiu PC; Chen JC; Huang YH; Lin SP; Chou YY; Ting WH; Wang SY; Chiu CF; Huang YC; Hsiao HP; Lin CH; Wang CH; Bau DT; Lin CY In Vivo; 2024; 38(1):341-350. PubMed ID: 38148081 [TBL] [Abstract][Full Text] [Related]
6. X-Linked Hypophosphatemia and FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment. Kinoshita Y; Fukumoto S Endocr Rev; 2018 Jun; 39(3):274-291. PubMed ID: 29381780 [TBL] [Abstract][Full Text] [Related]
7. Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program. Rush ET; Johnson B; Aradhya S; Beltran D; Bristow SL; Eisenbeis S; Guerra NE; Krolczyk S; Miller N; Morales A; Ramesan P; Sarafrazi S; Truty R; Dahir K J Bone Miner Res; 2022 Feb; 37(2):202-214. PubMed ID: 34633109 [TBL] [Abstract][Full Text] [Related]
8. Effects of Burosumab Treatment on Two Siblings with X-Linked Hypophosphatemia. Case Report and Literature Review. Jurca CM; Iuhas O; Kozma K; Petchesi CD; Zaha DC; Bembea M; Jurca S; Paul C; Jurca AD Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011303 [TBL] [Abstract][Full Text] [Related]
9. What are the benefits of the anti-FGF23 antibody burosumab on the manifestations of X-linked hypophosphatemia in adults in comparison with conventional therapy? A review. Lafage-Proust MH Ther Adv Rare Dis; 2022; 3():26330040221074702. PubMed ID: 37180412 [TBL] [Abstract][Full Text] [Related]
10. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells. Ichikawa S; Austin AM; Gray AK; Econs MJ J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791 [TBL] [Abstract][Full Text] [Related]
11. X-linked hypophosphatemia and burosumab: Practical clinical points from the French experience. Bacchetta J; Rothenbuhler A; Gueorguieva I; Kamenicky P; Salles JP; Briot K; Linglart A Joint Bone Spine; 2021 Oct; 88(5):105208. PubMed ID: 34102329 [TBL] [Abstract][Full Text] [Related]
12. X-Linked Hypophosphatemia: A New Era in Management. Dahir K; Roberts MS; Krolczyk S; Simmons JH J Endocr Soc; 2020 Dec; 4(12):bvaa151. PubMed ID: 33204932 [TBL] [Abstract][Full Text] [Related]
13. X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3'-UTR Mutation c.*231A>G (A Retrospective Case-Control Study). Smith PS; Gottesman GS; Zhang F; Cook F; Ramirez B; Wenkert D; Wollberg V; Huskey M; Mumm S; Whyte MP J Bone Miner Res; 2020 May; 35(5):920-931. PubMed ID: 31910300 [TBL] [Abstract][Full Text] [Related]
14. Pathogenic role of Fgf23 in Dmp1-null mice. Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986 [TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-mediated mutation of PHEX in rabbit recapitulates human X-linked hypophosphatemia (XLH). Sui T; Yuan L; Liu H; Chen M; Deng J; Wang Y; Li Z; Lai L Hum Mol Genet; 2016 Jul; 25(13):2661-2671. PubMed ID: 27126636 [TBL] [Abstract][Full Text] [Related]
16. Novel PHEX gene locus-specific database: Comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH). Sarafrazi S; Daugherty SC; Miller N; Boada P; Carpenter TO; Chunn L; Dill K; Econs MJ; Eisenbeis S; Imel EA; Johnson B; Kiel MJ; Krolczyk S; Ramesan P; Truty R; Sabbagh Y Hum Mutat; 2022 Feb; 43(2):143-157. PubMed ID: 34806794 [TBL] [Abstract][Full Text] [Related]
17. Congenital Conditions of Hypophosphatemia Expressed in Adults. Marcucci G; Brandi ML Calcif Tissue Int; 2021 Jan; 108(1):91-103. PubMed ID: 32409880 [TBL] [Abstract][Full Text] [Related]
18. Analysis of 2 novel mutations of PHEX gene inducing X-linked dominant hypophosphatemia rickets in 2 families: Two case reports. Gao Y; Wang ZM; Li XL Medicine (Baltimore); 2018 Aug; 97(31):e11453. PubMed ID: 30075510 [TBL] [Abstract][Full Text] [Related]
19. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets. Razali NN; Hwu TT; Thilakavathy K J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1009-17. PubMed ID: 25894638 [TBL] [Abstract][Full Text] [Related]